| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT02784743 | Lymphatic Filariasis | Drug: ''albendazole'' and ''ivermectin'' | Centre d'Appui la lutte contre la Maladie|Malaria Research and Training Center, Bamako, Mali|World Health Organization | Phase 4 | 2001-05-01 | 2016-05-24 |
| NCT01087099 | Infections With Soil-Transmitted Helminths (STH) | Drug: Albendazole | University Ghent|Ghent University, Faculty of Veterinary Medicine, Dpt of Virology, Parasitology and Immunology, Belgium|World Health Organization|George Washington University|Commonwealth Scientific and Industrial Research Organisation, Australia|University of Nottingham|Queensland Institute of Medical Research | Phase 4 | 2009-01-01 | 2011-07-30 |
| NCT02243644 | Neurocysticercosis | Drug: 7 days of albendazole 15 mg/kg/day|Drug: 28 days of albendazole 15 mg/kg/day | All India Institute of Medical Sciences, New Delhi | Phase 3 | 2014-03-01 | 2015-12-31 |
| NCT00511004 | Lymphatic Filariasis | Drug: Albendazole|Drug: Diethylcarbamazine | National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC) | Phase 2 | 2007-07-01 | 2015-07-30 |
| NCT00755560 | Toxocariasis | Drug: Albendazole|Drug: Placebo | Hospital de Nios R. Gutierrez de Buenos Aires|The Hospital for Sick Children | Phase 3 | 2008-09-01 | 2016-02-18 |
| NCT01755637 | Helminthiasis | Drug: Albendazole | GlaxoSmithKline | Phase 1 | 2012-04-01 | 2013-07-11 |
| NCT00441285 | Neurocysticercosis|Epilepsy | Drug: Praziquantel|Drug: Albendazole|Drug: ABZ Placebo|Drug: PZQ Placebo | Universidad Peruana Cayetano Heredia|National Institute of Neurological Disorders and Stroke (NINDS) | Phase 2|Phase 3 | 2010-01-01 | 2015-05-15 |
| NCT00765024 | Chronic Strongyloidiasis | Drug: Ivermectin|Drug: ivermectin|Drug: Albendazole | Mahidol University|Atlantic Laboratory Ltd | Phase 3 | 2008-07-01 | 2010-06-18 |
| NCT01192802 | Intestinal Diseases|Helminthiasis | Drug: albendazole|Drug: albendazole|Drug: albendazole | Albert Schweitzer Hospital | Phase 4 | 2010-08-01 | 2013-01-23 |
| NCT01213576 | Lymphatic Filariasis | Drug: Albendazole 400mg and ivermectin 200mcg/kg|Drug: Albendazole and ivermectin|Drug: Albendazole 400mg and ivermectin 200mcg/kg|Drug: albendazole 800mg and ivermectin 400mcg/kg bi-annually | London School of Hygiene and Tropical Medicine|Emory University | | 2009-01-01 | 2015-02-26 |
| NCT02420574 | Helminthiasis | Drug: albendazole BENDEX|Drug: albendazole OVIS | University Ghent | | 2014-02-01 | 2015-04-17 |
| NCT02636803 | Helminthiasis | Drug: oxfendazole|Drug: albendazole | Robert Gilman|Universidad Peruana Cayetano Heredia|Johns Hopkins Bloomberg School of Public Health | Phase 2 | 2017-11-01 | 2017-03-02 |
| NCT00002191 | Protozoan Infections|HIV Infections | Drug: Albendazole | SmithKline Beecham|NIH AIDS Clinical Trials Information Service | Phase 3 | | 2005-06-23 |
| NCT01440608 | Enteropathy | Drug: Albendazole|Drug: Placebo|Dietary Supplement: High-dose Zinc | Washington University School of Medicine | | 2011-10-01 | 2012-03-02 |
| NCT02876146 | Alveolar Echinococcosis | Drug: Benzimidazole | Centre Hospitalier Universitaire de Besancon | | 2012-06-01 | 2016-08-22 |
| NCT01975441 | Lymphatic Filariasis | Drug: Diethylcarbamazine|Drug: Albendazole|Drug: Ivermectin | University Hospitals Cleveland Medical Center | Phase 2 | 2014-05-01 | 2016-10-11 |
| NCT00659997 | Ascariasis|Trichuriasis | Drug: Albendazole|Drug: Levamisole | Natural History Museum, United Kingdom|Ministry of Health, Tanzania|University of London | Phase 4 | 2006-06-01 | 2008-04-15 |
| NCT02845713 | Wuchereria Bancrofti Infection | Drug: Ivermectin, Diethylcarbamazine Albendazole (IDA) | University Hospitals Cleveland Medical Center|Washington University School of Medicine | Phase 1 | 2016-04-01 | 2016-10-11 |
| NCT00375583 | Lymphatic Filariasis|Wuchereria Bancrofti Infection | Drug: DEC/Albendazole | National Institute of Allergy and Infectious Diseases (NIAID)|Tuberculosis Research Centre, India|National Institutes of Health Clinical Center (CC) | Phase 2 | 2006-09-09 | 2017-01-24 |
| NCT01395381 | Kwashiorkor|Marasmus | Drug: Placebo|Drug: Albendazole | Washington University School of Medicine|University of Malawi College of Medicine | | 2013-01-01 | 2014-01-24 |
| NCT00130910 | HIV Infections|Helminthiasis | Drug: Albendazole|Drug: Placebo | University of Washington|Kenya Medical Research Institute|University of Nairobi|Kenyatta National Hospital | | 2006-03-01 | 2007-11-13 |
| NCT00207753 | Ascariasis|Trichuriasis|Hookworm Infection|Strongyloidiasis|Pediculosis | Drug: albendazole vs. combined albendazole/ivermectin treatment | Centers for Disease Control and Prevention|Universidad del Valle, Guatemala | | 2005-02-01 | 2005-11-16 |
| NCT01903057 | Trachoma|Lymphatic Filariasis | Drug: azithromycin|Drug: ivermectin|Drug: albendazole|Drug: placebo | Emory University | Phase 4 | 2014-02-01 | 2014-05-21 |
| NCT00339417 | Lymphatic Filariasis | Drug: Albendazole|Drug: Ivermectin | National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC) | Phase 2 | 2006-02-22 | 2017-01-24 |
| NCT03032042 | Helminth Infection | Drug: Azithromycin|Drug: Albendazole|Drug: Delayed treatment | Francis I. Proctor Foundation | Phase 4 | 2017-01-01 | 2017-01-23 |
